Lumira Ventures
Lumira Ventures is a venture capital firm that specializes in investing in emerging, mid, and late-stage companies within the healthcare and life sciences sectors. Founded in 2007 and based in Toronto, Ontario, with additional offices in Montreal, Vancouver, and Boston, the firm primarily focuses on biotechnology, biopharmaceuticals, medical devices, digital health, and consumer health companies. Lumira Ventures typically invests between 5 million and 15 million in North American companies, emphasizing those located in Canada and the United States. The firm is committed to helping its portfolio companies enhance the value of their technology pipelines through active board participation and support in accessing additional funding sources and market opportunities. With a history that includes investments in over 100 healthcare companies, Lumira Ventures currently manages a portfolio of more than 30 active investee companies that aim to address significant unmet needs in the healthcare landscape.
HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused sound energy to generate pressures to liquify and completely destroy targeted tissues at sub-cellular levels.
HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused sound energy to generate pressures to liquify and completely destroy targeted tissues at sub-cellular levels.